Clinical trials
Recruiting Phase 2 Pulmonary Arterial Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bastiaan Driehuys | 4 |
| Merck Sharp & Dohme LLC | 2 |
| AllRock Bio, Inc. | 1 |
| Apollo Therapeutics Ltd | 1 |
| Gustavo A Heresi, MD, MS | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Regeneron Pharmaceuticals | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 12 |
| Hypertension, Pulmonary | 5 |
| Lung Diseases, Interstitial | 2 |
| Connective Tissue Diseases | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Heart Failure | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
| Ventricular Dysfunction, Right | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.